382 related articles for article (PubMed ID: 22728913)
1. Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Kar S; Bhatt DL
Coron Artery Dis; 2012 Sep; 23(6):380-90. PubMed ID: 22728913
[TBL] [Abstract][Full Text] [Related]
2. Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.
Khemasuwan D; Suramaethakul N
Clin Appl Thromb Hemost; 2012 Sep; 18(5):476-86. PubMed ID: 22387584
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Singh D; Gupta K; Vacek JL
Cleve Clin J Med; 2014 Feb; 81(2):103-14. PubMed ID: 24493493
[TBL] [Abstract][Full Text] [Related]
4. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
5. [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Vargas Ruiz AG; Ramírez López AN; Medina Viramontes ME
Gac Med Mex; 2012; 148(3):257-64. PubMed ID: 22820359
[TBL] [Abstract][Full Text] [Related]
6. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
7. Disadvantages of VKA and requirements for novel anticoagulants.
Shameem R; Ansell J
Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
[TBL] [Abstract][Full Text] [Related]
8. Novel oral anticoagulants in acute coronary syndrome.
Costopoulos C; Niespialowska-Steuden M; Kukreja N; Gorog DA
Int J Cardiol; 2013 Sep; 167(6):2449-55. PubMed ID: 22989603
[TBL] [Abstract][Full Text] [Related]
9. A review of oral anticoagulants in patients with atrial fibrillation.
Greenspon AJ
Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
[TBL] [Abstract][Full Text] [Related]
10. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
Morales-Vidal S; Schneck MJ; Flaster M; Biller J
Expert Rev Neurother; 2012 Feb; 12(2):179-89; quiz 190. PubMed ID: 22288673
[TBL] [Abstract][Full Text] [Related]
11. The need for novel anticoagulation therapy in acute coronary syndrome.
Chandrasekar S; Loomba R; Shah P; Arora R
Am J Ther; 2013 Jan; 20(1):61-6. PubMed ID: 21317627
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in antithrombotic therapy for stroke prevention in patients with atrial fibrillation.
Lenchus JD
Hosp Pract (1995); 2013 Feb; 41(1):49-60. PubMed ID: 23466967
[TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
Contractor T; Levin V; Martinez MW; Marchlinski FE
Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
[TBL] [Abstract][Full Text] [Related]
14. [Anticoagulant therapy in secondary prevention of coronary events].
Bultas J
Vnitr Lek; 2014 Dec; 60(12):1023-32. PubMed ID: 25692828
[TBL] [Abstract][Full Text] [Related]
15. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
16. New oral anticoagulants vs. warfarin treatment: no need for pharmacogenomics?
Baker WL; Chamberlin KW
Clin Pharmacol Ther; 2014 Jul; 96(1):17-9. PubMed ID: 24942397
[TBL] [Abstract][Full Text] [Related]
17. Treatment discontinuations with new oral agents for long-term anticoagulation: insights from a meta-analysis of 18 randomized trials including 101,801 patients.
Chatterjee S; Sardar P; Giri JS; Ghosh J; Mukherjee D
Mayo Clin Proc; 2014 Jul; 89(7):896-907. PubMed ID: 24996233
[TBL] [Abstract][Full Text] [Related]
18. [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Dumont B; Faille D; Ajzenberg N
Med Sci (Paris); 2011 May; 27(5):493-500. PubMed ID: 21609670
[TBL] [Abstract][Full Text] [Related]
19. [New antithrombotic drugs].
Mustonen P; Puurunen M
Duodecim; 2012; 128(7):707-18. PubMed ID: 22612021
[TBL] [Abstract][Full Text] [Related]
20. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
Kasmeridis C; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
